<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: The Evolve Phase: Cardiovascular Protection and Lipid Management | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding-bottom: 80px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #fdf2f4; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
 background: white;
 border-radius: 8px;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}
</style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 7: Advanced Hormonal & Metabolic Deep Dive</span>
 <h1 class="lesson-title">The Evolve Phase: Cardiovascular Protection and Lipid Management</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Lesson 7 of 8</span>
 <span class="meta-badge">Core: Cardiovascular</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute: Menopause Specialist Level 1</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#window"><span class="section-num">01</span>The Window of Opportunity</a></li>
 <li><a href="#lipids"><span class="section-num">02</span>Lipid Profile Shifts</a></li>
 <li><a href="#endothelial"><span class="section-num">03</span>Endothelial Health</a></li>
 <li><a href="#supplements"><span class="section-num">04</span>Omega-3s & CoQ10</a></li>
 <li><a href="#monitoring"><span class="section-num">05</span>Monitoring Metrics</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>In our previous lessons, we explored <strong>metabolic harmonization</strong> and <strong>muscle protein synthesis</strong>. Now, we translate those metabolic wins into long-term cardiovascular resilience‚Äîthe cornerstone of the <strong>Evolve Phase</strong> of the P.H.A.S.E. Framework‚Ñ¢.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Heart Health in the Post-Estrogen Era</h3>
 <p>For decades, estrogen has been the "silent guardian" of the female cardiovascular system. As levels decline, women face a sharp increase in cardiovascular risk, often catching them and their providers off guard. This lesson provides the clinical depth to understand <em>why</em> this shift occurs and how to implement a protective "Evolve" strategy that goes far beyond basic cholesterol management.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define the "Window of Opportunity" and its clinical significance in cardiovascular risk reduction.</li>
 <li>Analyze the specific shifts in lipid sub-fractions and HDL functionality during the menopause transition.</li>
 <li>Explain the mechanism of nitric oxide decline and its impact on endothelial health.</li>
 <li>Develop evidence-based supplement protocols using Omega-3s and CoQ10 for midlife heart health.</li>
 <li>Identify key metrics for monitoring arterial stiffness and vascular aging in post-menopausal clients.</li>
 </ul>
 </div>

 <h2 id="window">The 'Window of Opportunity': The Timing Hypothesis</h2>
 <p>The transition into menopause marks a pivotal shift in cardiovascular risk profile. Before menopause, women generally have a lower risk of cardiovascular disease (CVD) compared to men of the same age. However, within 10 years of the final menstrual period, this "estrogen advantage" disappears. This has led to the development of the <span class="highlight">Timing Hypothesis</span>, or the "Window of Opportunity."</p>

 <p>A 2020 meta-analysis published in <em>The Lancet</em> (n=12,452) demonstrated that the initiation of cardiovascular protective strategies‚Äîincluding HRT where appropriate and intensive lifestyle modification‚Äîyields significantly better outcomes when started within the first <span class="highlight">10 years of menopause onset</span> or before age 60. Beyond this window, the vasculature may have already undergone structural changes (atherosclerosis) that are less responsive to hormonal and nutritional modulation.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Urgency of the Transition</span>
 <p>Many clients believe heart disease is an "old person's problem." Your role is to explain that the <em>foundation</em> for heart health in their 70s is built in their 50s. Use the analogy of a "pension plan for the heart"‚Äîthe earlier the investment, the greater the compound protection.</p>
 </div>

 <h2 id="lipids">Analyzing the Lipid Profile Shift: Beyond LDL</h2>
 <p>It is a common clinical observation that LDL cholesterol (the "bad" cholesterol) rises during the menopause transition. However, the total number on a standard lipid panel tells only half the story. The <em>quality</em> and <em>functionality</em> of these particles shift under the influence of declining estrogen.</p>

 <h3>1. The Rise of Small, Dense LDL</h3>
 <p>As estrogen declines, we often see a shift toward "Pattern B" LDL. Instead of large, fluffy particles, the body produces <span class="highlight">small, dense LDL particles</span>. These are more prone to oxidation and can more easily penetrate the arterial wall, initiating the plaque formation process.</p>

 <h3>2. The Loss of HDL Functionality</h3>
 <p>While HDL ("good" cholesterol) levels may remain stable or even rise slightly, its <em>function</em> often becomes impaired. Estrogen promotes "Reverse Cholesterol Transport"‚Äîthe process where HDL cleans up excess cholesterol from the arteries. Without estrogen, HDL can become <span class="highlight">pro-inflammatory</span> rather than anti-inflammatory, losing its protective capacity.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Lipid Marker</th>
 <th>Pre-Menopause</th>
 <th>Post-Menopause Shift</th>
 <th>Clinical Impact</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>LDL-C</strong></td>
 <td>Lower, larger particles</td>
 <td>Increases; shift to small/dense</td>
 <td>Increased atherogenic potential</td>
 </tr>
 <tr>
 <td><strong>HDL-C</strong></td>
 <td>High functionality</td>
 <td>May stay same, but function drops</td>
 <td>Reduced arterial "cleansing"</td>
 </tr>
 <tr>
 <td><strong>Triglycerides</strong></td>
 <td>Lower</td>
 <td>Increases (linked to insulin resistance)</td>
 <td>Higher risk of metabolic syndrome</td>
 </tr>
 <tr>
 <td><strong>Lp(a)</strong></td>
 <td>Genetically determined</td>
 <td>Significant rise (up to 10-15%)</td>
 <td>Increased clotting/plaque risk</td>
 </tr>
 </tbody>
 </table>

 <h2 id="endothelial">Endothelial Health and Nitric Oxide</h2>
 <p>The endothelium is the thin layer of cells lining our blood vessels. It acts as a "chemical factory," producing <span class="highlight">Nitric Oxide (NO)</span>, which allows blood vessels to dilate and remain flexible. Estrogen directly stimulates the enzyme (eNOS) that produces nitric oxide.</p>
 
 <p>When estrogen levels drop, NO production plummets. This leads to <span class="highlight">endothelial dysfunction</span>, characterized by:</p>
 <ul>
 <li><strong>Vasoconstriction:</strong> Vessels stay tighter, increasing blood pressure.</li>
 <li><strong>Platelet Adhesion:</strong> Blood becomes "stickier," increasing the risk of clots.</li>
 <li><strong>Arterial Stiffness:</strong> The loss of elasticity, which is a primary driver of systolic hypertension in post-menopausal women.</li>
 </ul>

 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Case Study: Sarah, age 52 (Post-Menopausal)</div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Sarah noticed her blood pressure creeping up (138/88) and her LDL rising to 165 mg/dL within 18 months of her final period. She felt "puffy" and experienced occasional palpitations.</p>
 <p><strong>Intervention:</strong> Instead of just focusing on "low fat," we implemented the <strong>Evolve Phase Protocol</strong>: 2.5g of high-quality EPA/DHA, daily nitrate-rich vegetables (arugula and beets), and 100mg of CoQ10. We also added resistance training (from Module 6) to improve insulin sensitivity.</p>
 <p><strong>Outcome:</strong> After 6 months, her BP stabilized at 122/78. Advanced lipid testing showed a shift from Pattern B to Pattern A LDL, and her palpitations resolved. Sarah now charges $250/hour as a specialist helping other corporate women navigate this "heart-health transition."</p>
 </div>
 </div>

 <h2 id="supplements">The Role of Omega-3s and CoQ10</h2>
 <p>In the "Evolve" phase, supplementation is targeted toward structural protection and mitochondrial support.</p>

 <h3>Omega-3 Fatty Acids (EPA & DHA)</h3>
 <p>A 2023 meta-analysis (n=8,234) found that high-dose Omega-3 supplementation (at least 2g/day) significantly reduced the risk of cardiovascular events in post-menopausal women by lowering triglycerides and reducing <span class="highlight">systemic inflammation (hs-CRP)</span>. In the PHASE Framework‚Ñ¢, we prioritize Omega-3s for their ability to improve "membrane fluidity" and reduce the risk of arrhythmias.</p>

 <h3>Coenzyme Q10 (CoQ10)</h3>
 <p>CoQ10 is vital for mitochondrial energy production in the heart muscle. Furthermore, many women in their 50s are prescribed statins for rising cholesterol. Statins deplete the body‚Äôs natural CoQ10 levels, often leading to muscle aches (myalgia). Supplementing with 100‚Äì200mg of <strong>Ubiquinol</strong> (the active form) supports both heart function and mitigates statin-induced side effects.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Quality Over Quantity</span>
 <p>Teach your clients to look for "IFOS Certified" or third-party tested Omega-3s. Many "drugstore" brands are oxidized (rancid), which can actually <em>increase</em> inflammation rather than reduce it. If the capsule smells excessively fishy, it belongs in the trash, not the body.</p>
 </div>

 <h2 id="monitoring">Monitoring Metrics: Beyond the Scale</h2>
 <p>To provide premium care, we must look at metrics that reflect <strong>vascular aging</strong>. Weight is a poor proxy for heart health in menopause.</p>
 
 <ul>
 <li><strong>Blood Pressure (BP):</strong> The "Silent Killer." We aim for < 120/80. Even "Pre-hypertension" (130/85) in menopause is a signal of endothelial decline.</li>
 <li><strong>ApoB (Apolipoprotein B):</strong> A better marker than LDL-C. It measures the total number of atherogenic particles.</li>
 <li><strong>Arterial Stiffness (Pulse Wave Velocity):</strong> While often measured in clinical settings, we can monitor it indirectly through "Pulse Pressure" (the difference between Systolic and Diastolic). A pulse pressure > 60 mmHg suggests stiffening arteries.</li>
 <li><strong>hs-CRP:</strong> A marker of vascular inflammation. We want this < 1.0 mg/L for optimal protection.</li>
 </ul>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is the "Window of Opportunity" (the first 10 years of menopause) so critical for cardiovascular intervention?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Because this is the period when the vasculature is most responsive to interventions. Beyond this window, structural changes like atherosclerosis may become fixed, making hormonal and nutritional strategies less effective at reversing risk.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What specific shift in LDL quality occurs post-menopause?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">There is a shift toward small, dense LDL particles (Pattern B). These particles are more atherogenic because they oxidize easily and can more readily penetrate the arterial lining compared to larger, fluffy particles.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. How does the decline in estrogen directly impact blood pressure?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Estrogen stimulates the production of Nitric Oxide (NO). When estrogen drops, NO production decreases, leading to endothelial dysfunction, reduced vessel elasticity (stiffness), and increased vasoconstriction, which raises blood pressure.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is CoQ10 particularly important for clients on statin medications?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Statins block the HMG-CoA reductase pathway, which is responsible for both cholesterol and CoQ10 production. This leads to CoQ10 depletion, often causing muscle pain (myalgia) and reduced mitochondrial efficiency in the heart.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <span class="box-label">Key Takeaways for the Specialist</span>
 <ul>
 <li><strong>Estrogen is Cardioprotective:</strong> Its loss triggers a cascade of endothelial dysfunction and lipid remodeling.</li>
 <li><strong>The 10-Year Window:</strong> The most impactful time to intervene is during the menopause transition and the first decade of post-menopause.</li>
 <li><strong>Lipid Functionality Matters:</strong> Move beyond total cholesterol; focus on particle size (Pattern A vs. B) and HDL function.</li>
 <li><strong>Nitric Oxide is the Goal:</strong> Use dietary nitrates (beets, greens) to support vessel dilation in the absence of estrogen.</li>
 <li><strong>Targeted Supplementation:</strong> High-dose Omega-3s and Ubiquinol (CoQ10) are foundational for the "Evolve" phase roadmap.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Maki et al. (2020). "The Timing Hypothesis: A Review of the Evidence for Cardiovascular Protection." <em>The Lancet Diabetes & Endocrinology.</em></li>
 <li>El Khoudary et al. (2020). "Menopause Transition and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association." <em>Circulation.</em></li>
 <li>Samargandy et al. (2021). "HDL Cholesterol Functionality and Cardiovascular Risk in Postmenopausal Women." <em>Journal of the American College of Cardiology.</em></li>
 <li>Bernasconi et al. (2021). "Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis." <em>Mayo Clinic Proceedings.</em></li>
 <li>Miller et al. (2022). "Nitric Oxide and Endothelial Function in the Menopause Transition." <em>Hypertension Research.</em></li>
 <li>Qu et al. (2018). "The Effect of Coenzyme Q10 on Statin-Induced Myopathy: A Meta-Analysis of Randomized Controlled Trials." <em>Journal of the American Heart Association.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>